ShareValue scores for RHY.AU: Valuation 37, Quality 34, Growth 24, Health 48.
RHY.AUASX
RHYTHM Biosciences Ltd
A$0.10
(+5.43%)
RHY.AUASX
RHYTHM Biosciences Ltd
A$0.10(+5.43%)
Loading chart...
Sentiment
Verdicts
Value:Overvalued
Quality:Weak
Growth:Weak
Health:Moderate
Verdicts
Fundamental Rating
Value Trap Risk
Expected Return
-8% to 10%
Rating
Trap Risk
Return
-8% to 10%
Valuation
37
Overvalued
Price vs Value
Quality
34
Weak
Business Strength
Growth
24
Weak
Revenue & Earnings
Health
48
Moderate
Financial Stability
Momentum
32
Bearish
Price Trend
Company Details
About
Rhythm Biosciences Limited, a medical diagnostics company, provides blood tests for the detection of cancers in Australia and the United States. It offers ColoSTAT, a blood test for the early detection of colorectal cancer; and geneType, a personalized predictive test for predicting risk of chronic disease development. The company was incorporated in 2017 and is headquartered in Parkville, Australia.
Market Cap$34M
P/E RatioN/A
Dividend YieldNone
Sector Rank#2750
Score Analysis
AI Investment Thesis
Data as of:Aug 7, 2026
|Last calculated:Aug 7, 2026